These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
559 related items for PubMed ID: 9805982
1. [New NSAIDS: COX-1, COX-2, what about them?]. Peretz A. Rev Med Brux; 1998 Sep; 19(4):A399-402. PubMed ID: 9805982 [Abstract] [Full Text] [Related]
2. Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors, using sensitive microsomal and platelet assays. Riendeau D, Charleson S, Cromlish W, Mancini JA, Wong E, Guay J. Can J Physiol Pharmacol; 1997 Sep; 75(9):1088-95. PubMed ID: 9365818 [Abstract] [Full Text] [Related]
5. Efficacy, safety and potential clinical roles of the COX-2-specific inhibitors. van der Bijl P, van der Bijl P. Int J Immunopathol Pharmacol; 2003 Dec; 16(2 Suppl):17-22. PubMed ID: 14552700 [Abstract] [Full Text] [Related]
6. Scientific rationale for specific inhibition of COX-2. Bolten WW. J Rheumatol Suppl; 1998 May; 51():2-7. PubMed ID: 9596548 [Abstract] [Full Text] [Related]
16. New directions in cyclooxygenase research and their implications for NSAID-gastropathy. Flower RJ. Ital J Gastroenterol; 1996 Dec; 28 Suppl 4():23-7. PubMed ID: 9032578 [Abstract] [Full Text] [Related]
17. [Preferential COX-2 inhibition: its clinical relevance for gastrointestinal non-steroidal anti-inflammatory rheumatic drug toxicity]. Dammann HG. Z Gastroenterol; 1999 Jan; 37(1):45-58. PubMed ID: 10091284 [Abstract] [Full Text] [Related]
18. [Non-steroidal antiinflammatory drug--management of gastrointestinal complications and inhibition of COX-2]. Tada Y, Nagasawa K. Nihon Rinsho; 1999 Feb; 57(2):419-24. PubMed ID: 10078017 [Abstract] [Full Text] [Related]